|
ASB8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64834812466097E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.91304782915358E-13 |
| Normal-vs-Stage2 |
2.657900E-03 |
| Normal-vs-Stage3 |
7.47513162480118E-12 |
| Normal-vs-Stage4 |
1.58317803311547E-13 |
| Stage1-vs-Stage2 |
6.384100E-03 |
| Stage1-vs-Stage3 |
1.007190E-01 |
| Stage1-vs-Stage4 |
1.280500E-03 |
| Stage2-vs-Stage3 |
1.144320E-03 |
| Stage2-vs-Stage4 |
4.09860000000206E-05 |
| Stage3-vs-Stage4 |
1.559420E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.55111512312578E-15 |
| Normal-vs-AfricanAmerican |
1.038150E-04 |
| Normal-vs-Asian |
1.06330000027022E-07 |
| Caucasian-vs-AfricanAmerican |
3.813200E-01 |
| Caucasian-vs-Asian |
3.659200E-01 |
| AfricanAmerican-vs-Asian |
8.432800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.05560046551545E-12 |
| Normal-vs-Female |
2.0247137300089E-12 |
| Male-vs-Female |
4.190400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.54860585360939E-12 |
| Normal-vs-Age(41-60Yrs) |
2.70960032189294E-10 |
| Normal-vs-Age(61-80Yrs) |
5.87470072588303E-11 |
| Normal-vs-Age(81-100Yrs) |
1.736910E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.168000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.470600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.390200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.055000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.610600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.726600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.404000E-04 |
| Classical-VS-Follicular |
5.760800E-03 |
| Classical-VS-Other |
5.083600E-01 |
| Classical-VS-Normal |
1.71584968455818E-12 |
| Tall-VS-Follicular |
7.46070000001708E-07 |
| Tall-VS-Other |
3.653000E-01 |
| Tall-VS-Normal |
1.05582209641852E-13 |
| Follicular-VS-Other |
1.677630E-01 |
| Follicular-VS-Normal |
5.64370000000203E-05 |
| Other-VS-Normal |
1.598100E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.40359998360651E-09 |
| Normal-vs-N1 |
3.47499806707674E-14 |
| N0-vs-N1 |
3.54719999999809E-05 |
|
|
